Tissue Diagnostics Market By Product Type (Kits and Instruments), By Technology (Immuno Histochemistry, Digital Pathology, In-Situ Hybridization and Special Staining) By End User (Ambulatory Surgical Centers, Diagnostic Centers, Hospitals, and Research Laboratories) - Global Industry Analysis & Forecast to 2025

Published On : August 2018 Pages : 185 Category: Biotechnology Report Code : HC081183

Industry Outlook and Trend Analysis

Tissue diagnostics includes expulsion of tissue at a micro level from the patient's body, which is then analyzed, processed, and tested under the magnifying lens to identify different diseases like cancer. Progressions in the equipment and methods of tissue diagnostics helps for quick and exact assurance and assessment of diseases identified with the tissues. Increasing incidences of cancer, quick increment in aging populace, and development in the spending plans for healthcare drive the market. Nonetheless, budget limitations and high level of union control the market development. Additionally, developing markets and expanded usage of customized medicine provide lucrative opportunities for the development of the market.

Drivers and Restraints

With the increasing incidences of cancer, the market for tissue diagnostics has received significant traction over the world. The infrastructural advancement in the healthcare and medical industry is another critical factor that has helped the worldwide tissue diagnostics market generously over the previous couple of years. Over the upcoming years, the rising pattern of the qualitative and quantitative analyses of tissue tests, revelation of target particular antibodies in the biopharmaceutical business, and the developing awareness about tissue diagnosis in rising economies are anticipated to be the most conspicuous factors behind the development of this market.

Market Segmentation

The Tissue Diagnostic Market is segmented on the basis of product, technology and end user. Based on product the market is segmented into Kits and Instruments out of which the instruments segment surfaced as the major contributor of this market in 2015, holding a share of over 77%. With the increasing application of tissue diagnostic instruments in hospitals, diagnostic centers, and labs for speedier and accurate analysis, the demand is foreseen to rise strikingly over the following couple of years. Based on technology the market is segmented into Digital Pathology, Immuno Histochemistry, In-Situ Hybridization and Special Staining. On the basis of end user the market is segmented into Diagnostic Centers, Ambulatory Surgical Centers, Hospitals, and Research Laboratories out of which Hospitals, with a major share, has acquired the position of the main contributor to this market and is foreseen to retain this over the upcoming years.

Regional Outlook and Trend Analysis

The Middle East and Africa, North America, Asia Pacific, Latin America, and Europe have risen as the prevalent geological portions of the overall tissue diagnostic market. With a share of around 40%, North America enlisted predominance over these in 2015, on account of a well-settled pharmaceutical and biotechnology industry and the expansion in research exercises. Experts anticipate that this local market will stay on the best finished the following couple of years on the grounds of the surging exploration capital, advent of enhanced and mechanically propelled tissue diagnostic devices, and the existence of the main market players in a huge number.

Competitive Insights

The leading players in the market are Becton Dickinson, Agilent Technologies, Genomic Health, GE Healthcare, 3DHISTECH, Thermo Fisher Scientific, Roche Diagnostics, Cell Signaling Technology, Abbott Laboratories and Danaher Corporation. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Tissue Diagnostic Market is segmented based on regions as follows-

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Tissue Diagnostics Market, By Product Type, Estimates and Forecast, 2014-2025($Billion)

o    Kits

o    Instruments

·         Tissue Diagnostics Market, By Technology, Estimates and Forecast, 2014-2025($Billion)

o    Immuno Histochemistry

o    Digital Pathology

o    In-Situ Hybridization

o    Special Staining

·         Tissue Diagnostics Market, By End User, Estimates and Forecast, 2014-2025($Billion)

o    Ambulatory Surgical Centers

o    Diagnostic Centers

o    Hospitals

o    Research Laboratories

·         Tissue Diagnostics Market, By Region, Estimates and Forecast, 2014-2025($Billion)

o    North America

§  North America Tissue Diagnostics Market, By Country

o    U.S. Tissue Diagnostics Market

o    Canada Tissue Diagnostics Market

o    Mexico Tissue Diagnostics Market

o    Europe

§  Europe Tissue Diagnostics Market, By Country

o    Germany Tissue Diagnostics Market

o    UK Tissue Diagnostics Market

o    France Tissue Diagnostics Market

o    Russia Tissue Diagnostics Market

o    Italy Tissue Diagnostics Market

o    Rest of Europe Tissue Diagnostics Market

o    Asia-Pacific

§  Asia-Pacific Tissue Diagnostics Market, By Country

o    China Tissue Diagnostics Market

o    Japan Tissue Diagnostics Market

o    South Korea Tissue Diagnostics Market

o    India Tissue Diagnostics Market

o    Southeast Asia Tissue Diagnostics Market

o    Rest of Asia-Pacific Tissue Diagnostics Market

o    South America

§  South America Tissue Diagnostics Market

o    Brazil Tissue Diagnostics Market

o    Argentina Tissue Diagnostics Market

o    Columbia Tissue Diagnostics Market

o    Rest of South America Tissue Diagnostics Market

o    Middle East and Africa

§  Middle East and Africa Tissue Diagnostics Market

o    Saudi Arabia Tissue Diagnostics Market

o    UAE Tissue Diagnostics Market

o    Egypt Tissue Diagnostics Market

o    Nigeria Tissue Diagnostics Market

o    South Africa Tissue Diagnostics Market

o    Rest of MEA Tissue Diagnostics Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Tissue Diagnostics Market, By Product Type

5.1.     Introduction

5.2.     Global Tissue Diagnostics Revenue and Market Share by Product Type (2014-2018)

5.2.1.  Global Tissue Diagnostics Revenue and Revenue Share by Product Type (2014-2018)

5.3.     Kits

5.3.1.  Global Kits Revenue and Growth Rate (2014-2018)

5.4.     Instruments

5.4.1.  Global Instruments Revenue and Growth Rate (2014-2018)

6.       Tissue Diagnostics Market, By Technology

6.1.     Introduction

6.2.     Global Tissue Diagnostics Revenue and Market Share by Technology (2014-2018)

6.2.1.  Global Tissue Diagnostics Revenue and Revenue Share by Technology (2014-2018)

6.3.     Immuno Histochemistry

6.3.1.  Global Immuno Histochemistry Revenue and Growth Rate (2014-2018)

6.4.     Digital Pathology

6.4.1.  Global Digital Pathology Revenue and Growth Rate (2014-2018)

6.5.     In-Situ Hybridization

6.5.1.  Global In-Situ Hybridization Revenue and Growth Rate (2014-2018)

6.6.     Special Staining

6.6.1.  Global Special Staining Revenue and Growth Rate (2014-2018)

7.       Tissue Diagnostics Market, By End User

7.1.     Introduction

7.2.     Global Tissue Diagnostics Revenue and Market Share by End User (2014-2018)

7.2.1.  Global Tissue Diagnostics Revenue and Revenue Share by End User (2014-2018)

7.3.     Ambulatory Surgical Centers

7.3.1.  Global Ambulatory Surgical Centers Revenue and Growth Rate (2014-2018)

7.4.     Diagnostic Centers

7.4.1.  Global Diagnostic Centers Revenue and Growth Rate (2014-2018)

7.5.     Hospitals

7.5.1.  Global Hospitals Revenue and Growth Rate (2014-2018)

7.6.     Research Laboratories

7.6.1.  Global Research Laboratories Revenue and Growth Rate (2014-2018)

8.       Tissue Diagnostics Market, By Region

8.1.     Introduction

8.2.     Global Tissue Diagnostics Revenue and Market Share by Regions

8.2.1.  Global Tissue Diagnostics Revenue by Regions (2014-2018)

8.3.     North America Tissue Diagnostics by Countries

8.3.1.  North America Tissue Diagnostics Revenue and Growth Rate (2014-2018)

8.3.2.  North America Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)

8.3.3.  United States

8.3.3.1.  United States Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.4.  Canada

8.3.4.1.  Canada Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5.  Mexico

8.3.5.1.  Mexico Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.     Europe Tissue Diagnostics by Countries

8.4.1.  Europe Tissue Diagnostics Revenue and Growth Rate (2014-2018)

8.4.2.  Europe Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)

8.4.3.  Germany

8.4.3.1.  Germany Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.4.  France

8.4.4.1.  France Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5.  UK

8.4.5.1.  UK Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  Russia

8.4.6.1.  Russia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  Italy

8.4.7.1.  Italy Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.     Asia-Pacific Tissue Diagnostics by Countries

8.5.1.  Asia-Pacific Tissue Diagnostics Revenue and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)

8.5.3.  China

8.5.3.1.  China Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.4.  Japan

8.5.4.1.  Japan Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.  Korea

8.5.5.1.  Korea Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.  India

8.5.6.1.  India Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.     South America Tissue Diagnostics by Countries

8.6.1.  South America Tissue Diagnostics Revenue and Growth Rate (2014-2018)

8.6.2.  South America Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)

8.6.3.  Brazil

8.6.3.1.  Brazil Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.4.  Argentina

8.6.4.1.  Argentina Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5.  Columbia

8.6.5.1.  Columbia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.     Middle East and Africa Tissue Diagnostics by Countries

8.7.1.  Middle East and Africa Tissue Diagnostics Revenue and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5.  Egypt

8.7.5.1.  Egypt Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  South Africa

8.7.7.1.  South Africa Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  Turkey

8.7.8.1.  Turkey Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.     Becton Dickinson

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.  Financial Overview

9.2.     Agilent Technologies

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.  Financial Overview

9.3.     Genomic Health

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.  Financial Overview

9.4.     GE Healthcare

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.  Financial Overview

9.5.     3DHISTECH

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.  Financial Overview

9.6.     Thermo Fisher Scientific

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.  Financial Overview

9.7.     Roche Diagnostics

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.  Financial Overview

9.8.     Cell Signaling Technology

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.  Financial Overview

9.9.     Abbott Laboratories

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.  Financial Overview

9.10. Danaher Corporation

9.10.1.      Business Overview

9.10.2.       Service Portfolio

9.10.3.      Strategic Developments

9.10.4.      Financial Overview

10.    Tissue Diagnostics Market Forecast (2018-2025)

10.1. Global Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2018-2025)

10.2. Tissue Diagnostics Market Forecast by Regions (2018-2025)

10.2.1.      North America Tissue Diagnostics Market Forecast (2018-2025)

10.2.1.1. United States Tissue Diagnostics Market Forecast (2018-2025)

10.2.1.2. Canada Tissue Diagnostics Market Forecast (2018-2025)

10.2.1.3. Mexico Tissue Diagnostics Market Forecast (2018-2025)

10.2.2.      Europe Tissue Diagnostics Market Forecast (2018-2025)

10.2.2.1. Germany Tissue Diagnostics Market Forecast (2018-2025)

10.2.2.2. France Tissue Diagnostics Market Forecast (2018-2025)

10.2.2.3. UK Tissue Diagnostics Market Forecast (2018-2025)

10.2.2.4. Russia Tissue Diagnostics Market Forecast (2018-2025)

10.2.2.5. Italy Tissue Diagnostics Market Forecast (2018-2025)

10.2.2.6. Rest of Europe Tissue Diagnostics Market Forecast (2018-2025)

10.2.3.      Asia-Pacific Tissue Diagnostics Market Forecast (2018-2025)

10.2.3.1. China Tissue Diagnostics Market Forecast (2018-2025)

10.2.3.2. Japan Tissue Diagnostics Market Forecast (2018-2025)

10.2.3.3. Korea Tissue Diagnostics Market Forecast (2018-2025)

10.2.3.4. India Tissue Diagnostics Market Forecast (2018-2025)

10.2.3.5. Southeast Asia Tissue Diagnostics Market Forecast (2018-2025)

10.2.3.6. Rest of Asia-Pacific Tissue Diagnostics Market Forecast (2018-2025)

10.2.4.      South America Tissue Diagnostics Market Forecast (2018-2025)

10.2.4.1. Brazil Tissue Diagnostics Market Forecast (2018-2025)

10.2.4.2. Argentina Tissue Diagnostics Market Forecast (2018-2025)

10.2.4.3. Columbia Tissue Diagnostics Market Forecast (2018-2025)

10.2.4.4. Rest of South America Tissue Diagnostics Market Forecast (2018-2025)

10.2.5.      Middle East and Africa Tissue Diagnostics Market Forecast (2018-2025)

10.2.5.1. Saudi Arabia Tissue Diagnostics Market Forecast (2018-2025)

10.2.5.2. United Arab Emirates Tissue Diagnostics Market Forecast (2018-2025)

10.2.5.3. Egypt Tissue Diagnostics Market Forecast (2018-2025)

10.2.5.4. Nigeria Tissue Diagnostics Market Forecast (2018-2025)

10.2.5.5. South Africa Tissue Diagnostics Market Forecast (2018-2025)

10.2.5.6. Turkey Tissue Diagnostics Market Forecast (2018-2025)

10.2.5.7. Rest of Middle East and Africa Tissue Diagnostics Market Forecast (2018-2025)

10.3. Tissue Diagnostics Market Forecast by Product Type (2018-2025)

10.3.1.      Tissue Diagnostics Forecast by Product Type (2018-2025)

10.3.2.      Tissue Diagnostics Market Share Forecast by Product Type (2018-2025)

10.4. Tissue Diagnostics Market Forecast by Technology (2018-2025)

10.4.1.      Tissue Diagnostics Forecast by Technology (2018-2025)

10.4.2.      Tissue Diagnostics Market Share Forecast by Technology (2018-2025)

10.5. Tissue Diagnostics Market Forecast by End User (2018-2025)

10.5.1.      Tissue Diagnostics Forecast by End User (2018-2025)

10.5.2.      Tissue Diagnostics Market Share Forecast by End User (2018-2025)


List of Tables

Figure United States Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Tissue Diagnostics Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Tissue Diagnostics Revenue and Revenue Share by Product Type (2014-2018)
Figure Global Kits Revenue and Growth Rate (2014-2018)
Figure Global Instruments Revenue and Growth Rate (2014-2018)
Table Global Tissue Diagnostics Revenue and Revenue Share by Technology (2014-2018)
Figure Global Immuno Histochemistry Revenue and Growth Rate (2014-2018)
Figure Global Digital Pathology Revenue and Growth Rate (2014-2018)
Figure Global In-Situ Hybridization Revenue and Growth Rate (2014-2018)
Figure Global Special Staining Revenue and Growth Rate (2014-2018)
Table Global Tissue Diagnostics Revenue and Revenue Share by End User (2014-2018)
Figure Global Ambulatory Surgical Centers Revenue and Growth Rate (2014-2018)
Figure Global Diagnostic Centers Revenue and Growth Rate (2014-2018)
Figure Global Hospitals Revenue and Growth Rate (2014-2018)
Figure Global Research Laboratories Revenue and Growth Rate (2014-2018)
Table Global Tissue Diagnostics Revenue by Regions (2014-2018)
Figure North America Tissue Diagnostics Growth Rate (2014-2018)
Figure North America Tissue Diagnostics Revenue and Growth Rate (2014-2018)
Figure North America Tissue Diagnostics by Countries (2014-2018)
Figure North America Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)
Figure United States Tissue Diagnostics Growth Rate (2014-2018)
Figure United States Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Tissue Diagnostics Growth Rate (2014-2018)
Figure Canada Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Tissue Diagnostics Growth Rate (2014-2018)
Figure Mexico Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Tissue Diagnostics Growth Rate (2014-2018)
Figure Europe Tissue Diagnostics Revenue and Growth Rate (2014-2018)
Figure Europe Tissue Diagnostics by Countries (2014-2018)
Figure Europe Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)
Figure Germany Tissue Diagnostics Growth Rate (2014-2018)
Figure Germany Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Tissue Diagnostics Growth Rate (2014-2018)
Figure France Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Tissue Diagnostics Growth Rate (2014-2018)
Figure UK Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Tissue Diagnostics Growth Rate (2014-2018)
Figure Russia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Tissue Diagnostics Growth Rate (2014-2018)
Figure Italy Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Tissue Diagnostics Growth Rate (2014-2018)
Figure Rest of Europe Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Tissue Diagnostics Growth Rate (2014-2018)
Figure Asia-Pacific Tissue Diagnostics Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Tissue Diagnostics by Countries (2014-2018)
Figure Asia-Pacific Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)
Figure China Tissue Diagnostics Growth Rate (2014-2018)
Figure China Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Tissue Diagnostics Growth Rate (2014-2018)
Figure Japan Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Tissue Diagnostics Growth Rate (2014-2018)
Figure Korea Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Tissue Diagnostics Growth Rate (2014-2018)
Figure India Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Tissue Diagnostics Growth Rate (2014-2018)
Figure Southeast Asia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Tissue Diagnostics Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Tissue Diagnostics Growth Rate (2014-2018)
Figure South America Tissue Diagnostics Revenue and Growth Rate (2014-2018)
Figure South America Tissue Diagnostics by Countries (2014-2018)
Figure South America Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Tissue Diagnostics Growth Rate (2014-2018)
Figure Brazil Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Tissue Diagnostics Growth Rate (2014-2018)
Figure Argentina Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Tissue Diagnostics Growth Rate (2014-2018)
Figure Columbia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Tissue Diagnostics Growth Rate (2014-2018)
Figure Rest of South America Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Tissue Diagnostics Growth Rate (2014-2018)
Figure Middle East and Africa Tissue Diagnostics Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Tissue Diagnostics by Countries (2014-2018)
Figure Middle East and Africa Tissue Diagnostics Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Tissue Diagnostics Growth Rate (2014-2018)
Figure Saudi Arabia Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Tissue Diagnostics Growth Rate (2014-2018)
Figure United Arab Emirates Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Tissue Diagnostics Growth Rate (2014-2018)
Figure Egypt Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Tissue Diagnostics Growth Rate (2014-2018)
Figure Nigeria Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Tissue Diagnostics Growth Rate (2014-2018)
Figure South Africa Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Tissue Diagnostics Growth Rate (2014-2018)
Figure Turkey Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Tissue Diagnostics Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)
Table Becton Dickinson Tissue Diagnostics Financial Overview
Table Agilent Technologies Tissue Diagnostics Financial Overview
Table Genomic Health Tissue Diagnostics Financial Overview
Table GE Healthcare Tissue Diagnostics Financial Overview
Table 3DHISTECH Tissue Diagnostics Financial Overview
Table Thermo Fisher Scientific Tissue Diagnostics Financial Overview
Table Roche Diagnostics Tissue Diagnostics Financial Overview
Table Cell Signaling Technology Tissue Diagnostics Financial Overview
Table Abbott Laboratories Tissue Diagnostics Financial Overview
Table Danaher Corporation Tissue Diagnostics Financial Overview
Figure Global Tissue Diagnostics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Tissue Diagnostics Market Forecast by Regions (2018-2025)
Figure North America Tissue Diagnostics Market Forecast (2018-2025)
Figure United States Tissue Diagnostics Market Forecast (2018-2025)
Figure Canada Tissue Diagnostics Market Forecast (2018-2025)
Figure Mexico Tissue Diagnostics Market Forecast (2018-2025)
Figure Europe Tissue Diagnostics Market Forecast (2018-2025)
Figure Germany Tissue Diagnostics Market Forecast (2018-2025)
Figure France Tissue Diagnostics Market Forecast (2018-2025)
Figure UK Tissue Diagnostics Market Forecast (2018-2025)
Figure Russia Tissue Diagnostics Market Forecast (2018-2025)
Figure Italy Tissue Diagnostics Market Forecast (2018-2025)
Figure Rest of Europe Tissue Diagnostics Market Forecast (2018-2025)
Figure Asia-Pacific Tissue Diagnostics Market Forecast (2018-2025)
Figure China Tissue Diagnostics Market Forecast (2018-2025)
Figure Japan Tissue Diagnostics Market Forecast (2018-2025)
Figure Korea Tissue Diagnostics Market Forecast (2018-2025)
Figure India Tissue Diagnostics Market Forecast (2018-2025)
Figure Southeast Asia Tissue Diagnostics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Tissue Diagnostics Market Forecast (2018-2025)
Figure South America Tissue Diagnostics Market Forecast (2018-2025)
Figure Brazil Tissue Diagnostics Market Forecast (2018-2025)
Figure Argentina Tissue Diagnostics Market Forecast (2018-2025)
Figure Columbia Tissue Diagnostics Market Forecast (2018-2025)
Figure Rest of South America Tissue Diagnostics Market Forecast (2018-2025)
Figure Middle East and Africa Tissue Diagnostics Market Forecast (2018-2025)
Figure Saudi Arabia Tissue Diagnostics Market Forecast (2018-2025)
Figure United Arab Emirates Tissue Diagnostics Market Forecast (2018-2025)
Figure Egypt Tissue Diagnostics Market Forecast (2018-2025)
Figure Nigeria Tissue Diagnostics Market Forecast (2018-2025)
Figure South Africa Tissue Diagnostics Market Forecast (2018-2025)
Figure Turkey Tissue Diagnostics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Tissue Diagnostics Market Forecast (2018-2025)
Figure Global Tissue Diagnostics Forecast by Product Type (2018-2025)
Figure Global Tissue Diagnostics Market Share Forecast by Product Type (2018-2025)
Figure Global Tissue Diagnostics Forecast by Product Type (2018-2025)
Figure Global Tissue Diagnostics Forecast by Technology (2018-2025)
Figure Global Tissue Diagnostics Market Share Forecast by Technology (2018-2025)
Figure Global Tissue Diagnostics Forecast by Technology (2018-2025)
Figure Global Tissue Diagnostics Forecast by End User (2018-2025)
Figure Global Tissue Diagnostics Market Share Forecast by End User (2018-2025)
Figure Global Tissue Diagnostics Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*